Landen M

Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study.

Sandberg JV, Hansson C, Göteson A, ..., Pålsson E, Landén M

Mol. Psychiatry 27 (9) 3857-3863 [2022-09-00; online 2022-06-13]

Affinity Proteomics Uppsala [Service]

Cerebrospinal fluid proteomic study of two bipolar disorder cohorts.

Isgren A, Göteson A, Holmén-Larsson J, ..., Jakobsson J, Landén M

Mol. Psychiatry - (-) - [2022-08-19; online 2022-08-19]

Affinity Proteomics Uppsala [Service]

A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder.

Göteson A, Isgren A, Sparding T, ..., Pålsson E, Landén M

Transl Psychiatry 12 (1) 55 [2022-02-08; online 2022-02-08]

Affinity Proteomics Uppsala [Service]

Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder.

Göteson A, Isgren A, Jonsson L, ..., Holmén-Larsson J, Landén M

Mol. Psychiatry 26 (12) 7446-7453 [2021-12-00; online 2021-08-04]

Affinity Proteomics Uppsala [Service]

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.

Folkersen L, Gustafsson S, Wang Q, ..., Ingelsson E, Mälarstig A

Nat Metab 2 (10) 1135-1148 [2020-10-00; online 2020-10-16]

Affinity Proteomics Uppsala [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]